ENDRA Life Sciences

NDRANasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$7.297 M

$4.87 -1.52%

Close of 6 Nov 2026

As of 6 Nov 2026, ENDRA Life Sciences (NDRA) has a market capitalization of $7.30M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$7.03M

Loss-making

Shares outstanding

1,499,838

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 26 →

#21iTonicITOC$12.4M
#22IridexIRIX$12.1M
#23ENDRA Life SciencesNDRA$7.30M
#24NuwellisNUWE$1.87M
#25Nexalin TechnologyNXL$1.61M

What if ENDRA Life Sciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$18,825,687

Per share 3,869,617× higher

Bitcoin $1.53T

$1,018,625

Per share 209,378× higher

Apple $5.02T

$3,344,051

Per share 687,369× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for ENDRA Life Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.